{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:15:50Z","timestamp":1794539750652,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RDYR180418322304; Grant No: 116339"],"award-info":[{"award-number":["RDYR180418322304; Grant No: 116339"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emergence of <jats:italic>Candida auris<\/jats:italic> has been described as a global health threat due to its ability to cause invasive infections with high mortality rate and multidrug resistance. Novel drugs and therapies are required to target this organism and its pathogenicity. Anti-virulence approach and combination therapy have been proposed as alternatives in recent years. This study evaluated the virulence factors in <jats:italic>C. auris<\/jats:italic>, combination antifungal activity of phenolic compounds with antifungal drugs and determined effect of the most active compound on positive pathogenicity markers of <jats:italic>C. auris<\/jats:italic>. Antifungal susceptibility profile of 25 clinical isolates of <jats:italic>C. auris<\/jats:italic> against antifungal agents as well as against phenolic compounds was obtained using CLSI guidelines. Combination of the most active phenolic compound with antifungal drugs was determined. Effect of carvacrol on the virulence factors was also studied. Carvacrol was the most active phenol with median MIC of 125\u2009\u00b5g\/ml and its combination with fluconazole, amphotericin B, nystatin and caspofungin resulted synergistic and additive effects in 68%, 64%, 96% and 28%, respectively. Combination also reduced the MIC values of the drugs. All test strains showed adherence ability to epithelial cells and 96% of strains produced proteinase. None of the strains produced hyphae and phospholipase. At low concentrations, carvacrol significantly inhibited the adherence ability and proteinase production (both p\u2009&lt;\u20090.01). Carvacrol has antifungal and anti-virulence activity against <jats:italic>C. auris<\/jats:italic>. It also showed an enhanced antifungal activity in combination with antifungal agents. Therefore it has potential to be developed into a novel antifungal agent.<\/jats:p>","DOI":"10.1038\/s41598-020-58203-3","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T11:03:17Z","timestamp":1579863797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris"],"prefix":"10.1038","volume":"10","author":[{"given":"Siham","family":"Shaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrudula","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2845-0727","authenticated-orcid":false,"given":"Aijaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"58203_CR1","doi-asserted-by":"crossref","first-page":"e00029","DOI":"10.1128\/CMR.00029-17","volume":"31","author":"A Jeffery-Smith","year":"2018","unstructured":"Jeffery-Smith, A. et al. Candida auris: a Review of the Literature. Clin. Microbiol. Rev. 31, e00029\u201317 (2018).","journal-title":"Clin. Microbiol. Rev."},{"key":"58203_CR2","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.2174\/1381612822666160607072748","volume":"22","author":"A Ahmad","year":"2016","unstructured":"Ahmad, A., Molepo, J. & Patel, M. Challenges in the development of antifungal agents against Candida: scope of phytochemical research. Curr. Pharm. Des. 22, 4135\u20134150 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"58203_CR3","doi-asserted-by":"publisher","first-page":"e02396","DOI":"10.1128\/AAC.02396-16","volume":"61","author":"E Larkin","year":"2017","unstructured":"Larkin, E. et al. The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob. Agents. Chemother. 61, e02396\u201316 (2017).","journal-title":"Antimicrob. Agents. Chemother."},{"key":"58203_CR4","volume":"7","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg. Microbes. Infect. 7, 93 (2018).","journal-title":"Emerg. Microbes. Infect."},{"key":"58203_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","volume":"14","author":"K Gauwerky","year":"2009","unstructured":"Gauwerky, K., Borelli, C. & Korting, H. C. Targeting virulence: a new paradigm for antifungals. Drug Discov. Today. 14, 214\u2013222 (2009).","journal-title":"Drug Discov. Today."},{"key":"58203_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1399-302X.2004.00202.x","volume":"20","author":"N Chami","year":"2005","unstructured":"Chami, N., Bennis, S., Chami, F., Aboussekhra, A. & Remmal, A. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol. Immunol. 20, 106\u2013111 (2005).","journal-title":"Oral Microbiol. Immunol."},{"key":"58203_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1099\/jmm.0.008052-0","volume":"58","author":"N Guo","year":"2009","unstructured":"Guo, N. et al. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. J. Med. Microbiol. 58, 1074\u20131079 (2009).","journal-title":"J. Med. Microbiol."},{"key":"58203_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1055\/s-2003-37032","volume":"69","author":"LR Salgueiro","year":"2003","unstructured":"Salgueiro, L. R. et al. Chemical composition and antifungal activity of the essential oil of Origanum virens on Candida species. Planta Med. 69, 871\u2013874 (2003).","journal-title":"Planta Med."},{"key":"58203_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1439-0507.2007.01412.x","volume":"50","author":"PC Braga","year":"2007","unstructured":"Braga, P. C., Alfieri, M., Culici, M. & Dal Sasso, M. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses. 50, 502\u2013506 (2007a).","journal-title":"Mycoses."},{"key":"58203_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijantimicag.2007.12.013","volume":"31","author":"PC Braga","year":"2008","unstructured":"Braga, P. C., Culici, M., Alfieri, M. & Dal Sasso, M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int. J. Antimicrob. Agents. 31, 472\u2013477 (2008).","journal-title":"Int. J. Antimicrob. Agents."},{"key":"58203_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijantimicag.2008.01.028","volume":"31","author":"S Dalleau","year":"2008","unstructured":"Dalleau, S., Cateau, E., Berg\u00e8s, T., Berjeaud, J. M. & Imbert, C. In vitro activity of terpenes against Candida biofilms. Int. J. Antimicrob. Agents. 31, 572\u2013576 (2008).","journal-title":"Int. J. Antimicrob. Agents."},{"key":"58203_CR12","first-page":"401","volume":"8","author":"SS Hosseini","year":"2016","unstructured":"Hosseini, S. S., Yadegari, M. H., Rajabibazl, M. & Ghaemi, E. A. Inhibitory effects of carvacrol on the expression of secreted aspartyl proteinases 1-3 in fluconazole-resistant Candida albicans isolates. Iran J. Microbiol. 8, 401\u2013409 (2016).","journal-title":"Iran J. Microbiol."},{"key":"58203_CR13","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1128\/AAC.39.11.2459","volume":"39","author":"MA Ghannoum","year":"1995","unstructured":"Ghannoum, M. A. et al. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob. Agents Chemother. 39, 2459\u20132465 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"58203_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.phymed.2010.02.012","volume":"17","author":"A Khan","year":"2010","unstructured":"Khan, A., Ahmad, A., Xess, I., Khan, L. A. & Manzoor, N. Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole. Phytomedicine. 17, 921\u2013925 (2010).","journal-title":"Phytomedicine."},{"key":"58203_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/ptr.1594","volume":"18","author":"R Giordani","year":"2004","unstructured":"Giordani, R. et al. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother. Res. 18, 990\u2013995 (2004).","journal-title":"Phytother. Res."},{"key":"58203_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.fitote.2007.02.022","volume":"78","author":"PC Braga","year":"2007","unstructured":"Braga, P. C., Sasso, M. D., Culici, M. & Alfieri, M. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans. Fitoterapia. 78, 396\u2013400 (2007b).","journal-title":"Fitoterapia."},{"key":"58203_CR17","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0190-9622(98)70482-7","volume":"38","author":"KC Hazen","year":"1998","unstructured":"Hazen, K. C. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J. Am. Acad. Dermatol. 38, S37\u201341 (1998).","journal-title":"J. Am. Acad. Dermatol."},{"key":"58203_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/myc.12904","volume":"62","author":"SA Lone","year":"2019","unstructured":"Lone, S. A. & Ahmad, A. Candida auris - the growing menace to global health. Mycoses. 62, 620\u2013637 (2019).","journal-title":"Mycoses."},{"key":"58203_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10096-010-1050-8","volume":"30","author":"A Ahmad","year":"2011","unstructured":"Ahmad, A. et al. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur. J. Clin. Microbiol. Infect. Dis. 30, 41\u201350 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"58203_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/IAI.49.3.571-575.1985","volume":"49","author":"KJ Kwon-Chung","year":"1985","unstructured":"Kwon-Chung, K. J., Lehman, D., Good, C. & Magee, P. T. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49, 571\u2013575 (1985).","journal-title":"Infect. Immun."},{"key":"58203_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/0748233713506771","volume":"32","author":"H T\u00fcrkez","year":"2016","unstructured":"T\u00fcrkez, H. & Ayd\u0131n, E. Investigation of cytotoxic, genotoxic and oxidative properties of carvacrol in human blood cells. Toxicol. Ind. Health. 32, 625\u2013633 (2016).","journal-title":"Toxicol. Ind. Health."},{"key":"58203_CR22","doi-asserted-by":"publisher","first-page":"e0120937","DOI":"10.1371\/journal.pone.0120937","volume":"10","author":"I Cacciatore","year":"2015","unstructured":"Cacciatore, I. et al. Carvacrol codrugs: a new approach in the antimicrobial plan. PLoS One. 10, e0120937 (2015).","journal-title":"PLoS One."},{"key":"58203_CR23","first-page":"31","volume":"129","author":"F Macdonald","year":"1983","unstructured":"Macdonald, F. & Odds, F. C. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129, 31\u2013438 (1983).","journal-title":"J. Gen. Microbiol."},{"key":"58203_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","volume":"67","author":"JR Naglik","year":"2003","unstructured":"Naglik, J. R., Challacombe, S. J. & Hube, B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400\u2013228 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"58203_CR25","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1128\/IAI.65.12.5289-5294.1997","volume":"65","author":"NK Gaur","year":"1997","unstructured":"Gaur, N. K. & Klotz, S. A. Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect. Immun. 65, 5289\u20135294 (1997).","journal-title":"Infect. Immun."},{"key":"58203_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0966-842X(01)01984-9","volume":"9","author":"LL Hoyer","year":"2001","unstructured":"Hoyer, L. L. The ALS gene family of Candida albicans. Trends Microbiol. 9, 176\u2013180 (2001).","journal-title":"Trends Microbiol."},{"key":"58203_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/j.1365-2672.2000.00943.x","volume":"88","author":"SD Cox","year":"2000","unstructured":"Cox, S. D. et al. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J. Appl. Microbiol. 88, 170\u2013175 (2000).","journal-title":"J. Appl. Microbiol."},{"key":"58203_CR28","doi-asserted-by":"publisher","first-page":"261978","DOI":"10.1155\/2013\/261978","volume":"2013","author":"SD Naicker","year":"2013","unstructured":"Naicker, S. D. & Patel, M. Dodonaea viscosa var. angustifolia inhibits germ tube and biofilm formation by C. albicans. Evid. Based Complement. Alternat. Med. 2013, 261978 (2013).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"58203_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2302.161320","volume":"23","author":"L Sherry","year":"2017","unstructured":"Sherry, L. et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg. Infect. Dis. 23, 328\u2013331 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"58203_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3855\/jidc.4582","volume":"9","author":"D Kumar","year":"2015","unstructured":"Kumar, D., Banerjee, T., Pratap, C. & Tilak, R. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J. Infect. Dev. Ctries. 9, 435\u2013437 (2015).","journal-title":"J. Infect. Dev. Ctries."},{"key":"58203_CR31","doi-asserted-by":"publisher","first-page":"e1007638","DOI":"10.1371\/journal.ppat.1007638","volume":"15","author":"JE Nett","year":"2019","unstructured":"Nett, J. E. Candida auris: An emerging pathogen \u201cincognito\u201d? PLoS Pathog. 15, e1007638 (2019).","journal-title":"PLoS Pathog."},{"key":"58203_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000238524","volume":"33","author":"A Polak","year":"1987","unstructured":"Polak, A. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy. 33, 381\u2013395 (1987).","journal-title":"Chemotherapy."},{"key":"58203_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF01639520","volume":"17","author":"A Polak","year":"1987","unstructured":"Polak, A. Combination therapy for systemic mycosis. Infection. 17, 203\u2013209 (1987).","journal-title":"Infection."},{"key":"58203_CR34","unstructured":"Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts. informat. Wayne, Pennsylvania 19087 USA (2008)."},{"key":"58203_CR35","doi-asserted-by":"publisher","first-page":"e0145053","DOI":"10.1371\/journal.pone.0145053","volume":"10","author":"A Ahmad","year":"2015","unstructured":"Ahmad, A., Wani, M. Y., Khan, A., Manzoor, N. & Molepo, J. Synergistic interactions of eugenol tosylate and its congeners with fluconazole against Candida albicans. Plos one. 10, e0145053 (2015).","journal-title":"Plos one."},{"key":"58203_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jep.2009.05.002","volume":"124","author":"M Patel","year":"2009","unstructured":"Patel, M., Gulube, Z. & Dutton, M. The effect of Dodonaea viscosa var. angustifolia on Candida albicans proteinase and phospholipase production and adherence to oral epithelial cells. J. Ethnopharmacol. 124, 562\u2013565 (2009).","journal-title":"J. Ethnopharmacol."},{"key":"58203_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3109\/13693786.2010.539629","volume":"49","author":"S Yousuf","year":"2011","unstructured":"Yousuf, S., Ahmad, A., Khan, A., Manzoor, N. & Khan, L. A. Effect of garlic-derived allyl sulphides on morphogenesis and hydrolytic enzyme secretion in Candida albicans. Med. Mycol. 49, 444\u2013448 (2011).","journal-title":"Med. Mycol."},{"key":"58203_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1439-0507.2002.00727.x","volume":"45","author":"AS Kantarcioglu","year":"2002","unstructured":"Kantarcioglu, A. S. & Y\u00fccel, A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses. 45, 160\u2013165 (2002).","journal-title":"Mycoses."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58203-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:30:07Z","timestamp":1670308207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58203-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58203"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58203-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"16 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1162"}}